INSIGHTS ON PHARMACEUTICAL PACKAGING
-
Determining The Limit Of Detection In CCIT
Accurately determining the smallest detectable defect in pharmaceutical packaging is essential for sterility. Learn how test sensitivity, positive controls, and regulatory standards shape CCI strategies.
-
Providing Packing And Blinding Solutions For An Innovative Drug Start-Up
Discover how a CDMO with integrated services enabled a botanical drug start-up to commence its Phase 1 clinical trial, paving the way for further advancement of its innovative botanical drug.
-
FAQs On The Revised EU GMP Annex 1: Volume 1
The revised GMP Annex 1 guidelines emphasize quality risk management, enhanced environmental monitoring, and data integrity, which aim to minimize contamination and ensure patient safety.
-
Designing Robust Studies To Meet Auto-Injector Performance Requirements
Learn more about the critical tests for ensuring the proper performance of auto-injectors, which are used for a variety of applications ranging from emergency use to treating chronic conditions.
-
PCI Pharma Services Capabilities Update January 2026: Fill/Finish1/27/2026
Patricia Krainski highlights PCI’s global sterile fill‑finish and lyophilization strengths, showcasing investments that expand capacity, technologies, and integrated solutions for complex biologics, formulations, and lyophilized products.
-
Ensuring Tablet Logo Legibility: A Critical Step In Preventing Medication Errors11/11/2024
Tablet debossing aids medication identification and must meet FDA standards. Font, scale, color, shadow, and stroke details are key for optimal legibility and safety.
-
Key Considerations When Choosing A Device For Dry Powder Nasal Delivery10/21/2024
Building on previous discussions, here we discuss the benefits of nasal delivery and the challenges of developing dry powder formulations by focusing on key devices that can be used for delivering dry powder nasal dosage forms.
-
Achieving EU GMP Annex 1 Compliance For Contamination Control3/4/2025
Gain insight into three areas that have been key in ensuring a robust contamination control strategy to help ensure compliance with the updated Annex 1 regulation: planning, people, and products.
-
Establishing And Safeguarding Shelf Life In Combination Products10/27/2025
Establishing combination product shelf life requires aligning stability. Holistic, data-driven stability studies ensure product function, safety, and label claims through the entire supply chain.
PHARMACEUTICAL PACKAGING SOLUTIONS
-
The 362M two-sided labeling machine brings precision and versatility to your production line. This high-speed workhorse labels up to 200 products per minute, even those with challenging shapes.
-
PCI is committed to supporting clients at every stage of the clinical cycle, delivering best-in-class services efficiently and effectively. We deliver a seamless clinical service including pharmaceutical development, clinical manufacturing, labeling, storage and distribution.
-
The 362E TE is a versatile labeling machine that prioritizes safety and efficiency, ensuring accurate and tamper-evident labeling of folding boxes while maintaining rigorous quality control.
-
Efficient, customizable, intuitive use
Advanced bottom inspection of a variety of packages. The system supports customized lighting and can be extended with top cameras for further applications such as seal contamination inspection.
Effective Bottom Inspection
Supporting up to 400 ppm, capture the nuances associated with various product shapes or sizes where a larger field of view is required.
Application Based Design
Cameras and advanced lighting options help overcome challenging applications where wet, reflective, or uneven surfaces interfere with imaging.
Intuitive Software
Powerful CIVCore software offers a range of inspection options for easy setup and configuration.
-
The FlexPack NF-150 Horizontal Pouch-Packaging Machine is a high-performance packaging machine due to its versatility, productivity, and easy changeover.